Kolexia
Beauvais David Hématologie
Beauvais David
Hématologie
Hôpital Huriez
Lille, France
110 Activités
46 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Lymphome B diffus à grandes cellules Leucémies Maladie du greffon contre l'hôte Tumeurs hématologiques Leucémie aigüe myéloïde Leucémie-lymphome lymphoblastique à précurseurs B et T Infections à cytomégalovirus

Collaborateurs

Voir plus
Yakoub-Agha Ibrahim
Yakoub-Agha Ibrahim
Centre Hospitalier de Lille, Lille, France
Morschhauser Franck
Morschhauser Franck
Centre Hospitalier de Lille, Lille, France
Di Blasi Roberta
Di Blasi Roberta
Hôpital Saint-Louis, Paris, France
Mohty Mohamad
Mohty Mohamad
Hôpital Saint-Antoine, Paris, France

Industries

Voir plus
Gilead
17 collaboration(s)
Dernière en 2023
MSD
4 collaboration(s)
Dernière en 2023
BMS
2 collaboration(s)
Dernière en 2023
ALLOVIR INC
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
A second round of anti-CD19 CAR T-cell therapy in diffuse large B-cell lymphoma: when persistence pays off.
Leukemia & lymphoma   05 mars 2024
On behalf of the SFGM-TC: Real-life use of third-party virus-specific T-cell transfer in immunocompromised transplanted patients.
HemaSphere   27 janvier 2024
Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
Checkpoint Inhibitors and Allo-SCT in Hodgkin Lymphoma: A Matter of Time - a Study By the SFGM-TC
65th ASH Annual Meeting Abstracts   02 novembre 2023
Pooled Fecal Allogenic Microbiotherapy for Refractory Gastrointestinal Acute Graft-Versus-Host Disease : Results from Early Access Program in Europe
65th ASH Annual Meeting Abstracts   02 novembre 2023
Efficacy of CD19-Directed CAR T Cell Therapy in Patients with Primary or Secondary CNS Lymphoma - an Analysis of the EBMT Lymphoma WP and the Gocart Coalition
65th ASH Annual Meeting Abstracts   02 novembre 2023
Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.
Blood advances   01 novembre 2023
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
Essai Clinique (Novartis)   25 septembre 2023
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.
Bone marrow transplantation   25 septembre 2023
Efficacy and toxicity of CAR T-cell therapy in patients with primary and secondary central nervous system lymphoma—an analysis of the EBMT Lymphoma WP and the GoCART coalition
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023